Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study.

Wanda M, Mengjie L, Jingyao W, Xue S, Xiao W, Cairong L, Yachao L, Zhigang Z, Zengming X

Open source

DOI
10.3389/fcvm.2026.1798099
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1798099,
  title = {Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study.},
  author = {Wanda M and Mengjie L and Jingyao W and Xue S and Xiao W and Cairong L and Yachao L and Zhigang Z and Zengming X},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1798099},
  url = {https://doi.org/10.3389/fcvm.2026.1798099}
}

RIS

TY  - JOUR
TI  - Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study.
AU  - Wanda M
AU  - Mengjie L
AU  - Jingyao W
AU  - Xue S
AU  - Xiao W
AU  - Cairong L
AU  - Yachao L
AU  - Zhigang Z
AU  - Zengming X
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1798099
UR  - https://doi.org/10.3389/fcvm.2026.1798099
ER  - 

APA

M, W., L, M., W, J., S, X., W, X., L, C., L, Y., Z, Z., & X, Z. (2026). Long-term single antiplatelet therapy for patients with acute coronary syndrome at high-risk for ischemia and bleeding: a precision cohort study.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1798099

Source records